Myoblast sensitivity and fibroblast insensitivity to osteogenic conversion by BMP-2 correlates with the expression of Bmpr-1a

BMC Musculoskeletal Disorders

Volumn 10, Issue , 2009, Pages

  Liu, Renjing ^a,b   Ginn, Samantha L ^a   Lek, Monkol ^a,b   North, Kathryn N ^a,b   Alexander, Ian E ^a,b   Little, David G ^a,b   Schindeler, Aaron ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; LENTIVIRUS VECTOR; MYOD PROTEIN; OSTEOCALCIN; BIOLOGICAL MARKER; BMP2 PROTEIN, MOUSE; BMPR1A PROTEIN, MOUSE; BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; MYOD1 MYOGENIC DIFFERENTIATION PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; BONE DEVELOPMENT; BONE MINERALIZATION; BONE TISSUE; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; HUMAN; MESENCHYMAL STEM CELL; MOUSE; MUSCLE DEVELOPMENT; MUSCLE TISSUE; MYOBLAST; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL STRAIN 3T3; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; FEEDBACK SYSTEM; GENETICS; METABOLISM; METHODOLOGY; PHYSIOLOGY; STEM CELL; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; FEEDBACK, BIOCHEMICAL; FIBROBLASTS; MICE; MICE, INBRED C57BL; MYOBLASTS; MYOD PROTEIN; NIH 3T3 CELLS; OSTEOGENESIS; STEM CELLS; TRANSDUCTION, GENETIC; UP-REGULATION;

EID: 66249106070     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-10-51     Document Type: Article

References (45)

1. Cbfa1 as a regulator of osteoblast differentiation and function. G Karsenty P Ducy M Starbuck M Priemel J Shen V Geoffroy M Amling, Bone 1999 25 107 8 10.1016/S8756-3282(99)00111-8 10423032
2. Bone morphogenetic proteins, their antagonists, and the skeleton. E Canalis AN Economides E Gazzerro, Endocrine Reviews 2003 24 218 35 10.1210/er.2002-0023 12700180
3. Signal transduction by bone morphogenetic proteins. M Kawabata T Imamura K Miyazono, Cytokine & Growth Factor Reviews 1998 9 49 61 10.1016/S1359-6101(97)00036-1 9720756
4. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. K Miyazono S Maeda T Imamura, Cytokine & Growth Factor Reviews 2005 16 251 63 10.1016/j.cytogfr.2005.01.009 15871923
5. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. BB Koenig JS Cook DH Wolsing J Ting JP Tiesman PE Correa CA Olson AL Pecquet F Ventura RA Grant, Mol Cell Biol 1994 14 5961 74 8065329 (Pubitemid 24264425)
6. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. P ten Dijke H Yamashita TK Sampath AH Reddi M Estevez DL Riddle H Ichijo CH Heldin K Miyazono, Journal of Biological Chemistry 1994 269 16985 8 8006002 (Pubitemid 24204009)
7. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. LC Gerstenfeld DM Cullinane GL Barnes DT Graves TA Einhorn, Journal of Cellular Biochemistry 2003 88 873 84 10.1002/jcb.10435 12616527
8. Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. F Kugimiya H Kawaguchi S Kamekura H Chikuda S Ohba F Yano N Ogata T Katagiri Y Harada Y Azuma K Nakamura UI Chung, Journal of Biological Chemistry 2005 280 35705 12 10.1074/jbc.M505166200
9. Defective osteogenesis of the stromal stem cells predisposes CD18-null mice to osteoporosis. Y Miura M Miura S Gronthos MR Allen C Cao TE Uveges Y Bi D Ehirchiou A Kortesidis S Shi L Zhang, Proceedings of the National Academy of Sciences of the United States of America 2005 102 14022 7 16172402 10.1073/pnas.0409397102
10. Osteogenesis in transplants of bone marrow cells. AJ Friedenstein II Piatetzky-Shapiro KV Petrakova, Journal of Embryology & Experimental Morphology 1966 16 381 90
11. Circulating osteoblast-lineage cells in humans. GZ Eghbali-Fatourechi J Lamsam D Fraser D Nagel BL Riggs S Khosla, New England Journal of Medicine 2005 352 1959 66 10.1056/NEJMoa044264 15888696
12. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. S Otsuru K Tamai T Yamazaki H Yoshikawa Y Kaneda, Biochemical & Biophysical Research Communications 2007 354 453 8 10.1016/j.bbrc.2006.12.226
13. The contribution of different cell lineages to bone repair: Exploring a role for muscle stem cells. A Schindeler R Liu DG Little, Differentiation 2009 77 12 8 19281760
14. Transdifferentiation: an attractive concept in search of evidence. JE Rasko, Pathology 2003 35 5 10.1080/0031302021000062253 12701677
15. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. T Katagiri A Yamaguchi M Komaki E Abe N Takahashi T Ikeda V Rosen JM Wozney A Fujisawa-Sehara T Suda, Journal of Cell Biology 1994 127 1755 66 7798324 10.1083/jcb.127.6.1755
16. Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. LC Yeh AD Tsai JC Lee, Journal of Cellular Biochemistry 2002 87 292 304 10.1002/jcb.10315 12397611
17. Heterotopic ossification: a review. L Vanden Bossche G Vanderstraeten, Journal of Rehabilitation Medicine 2005 37 129 36 10.1080/16501970510027628 16040468
18. BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. V Wright H Peng A Usas B Young B Gearhart J Cummins J Huard, Molecular Therapy: the Journal of the American Society of Gene Therapy 2002 6 169 78 12161183 (Pubitemid 36336124)
19. BMP type I receptor inhibition reduces heterotropic ossification. PB Yu DY Deng CS Lai CC Hong GD Cuny ML Bouxsein DW Hong PM McManus T Katagiri C Sachidanandan N Kamiya T Fukuda Y Mishina RT Peterson KD Bloch, Nature Medicine 2008 14 1363 9 10.1038/nm.1888 19029982
20. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. A Dellavalle M Sampaolesi R Tonlorenzi E Tagliafico B Sacchetti L Perani A Innocenzi BG Galvez G Messina R Morosetti S Li M Belicchi G Peretti JS Chamberlain WE Wright Y Torrente S Ferrari P Bianco G Cossu, Nature Cell Biology 2007 9 255 67 10.1038/ncb1542 17293855
21. Osteoprogenitor cells within skeletal muscle. P Bosch DS Musgrave JY Lee J Cummins T Shuler TC Ghivizzani T Evans TD Robbins J Huard, Journal of Orthopaedic Research 2000 18 933 44 10.1002/jor.1100180613 11192254
22. Osteoprogenitor cells of mature human skeletal muscle tissue: an in vitro study. MM Levy CJ Joyner AS Virdi A Reed JT Triffitt AH Simpson J Kenwright H Stein MJ Francis, Bone 2001 29 317 22 10.1016/S8756-3282(01)00585-3 11595613
23. Use of myoblasts in assaying the osteoinductivity of bone morphogenetic proteins. L Jortikka M Laitinen J Wiklund TS Lindholm A Marttinen, Life Sciences 1998 62 2359 68 10.1016/S0024-3205(98)00218-5 9651102
24. Repair of calvarial defects with flap tissue: role of bone morphogenetic proteins and competent responding tissues. RK Khouri DM Brown B Koudsi EG Deune LA Gilula BC Cooley AH Reddi, Plastic & Reconstructive Surgery 1996 98 103 9 10.1097/00006534-199607000-00017
25. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. JY Lee D Musgrave D Pelinkovic K Fukushima J Cummins A Usas P Robbins FH Fu J Huard, Journal of Bone & Joint Surgery - American Volume 2001 83-A 1032 9 (Pubitemid 32662105)
26. Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. JY Lee H Peng A Usas D Musgrave J Cummins D Pelinkovic R Jankowski B Ziran P Robbins J Huard, Human Gene Therapy 2002 13 1201 11 10.1089/104303402320138989 12133273
27. Ex vivo gene therapy to produce bone using different cell types. DS Musgrave P Bosch JY Lee D Pelinkovic SC Ghivizzani J Whalen C Niyibizi J Huard, Clinical Orthopaedics & Related Research 2000 378 290 305 10.1097/00003086-200009000-00040
28. The effect of bone morphogenetic protein-2 expression on the early fate of skeletal muscle-derived cells. DS Musgrave R Pruchnic V Wright P Bosch SC Ghivizzani PD Robbins J Huard, Bone 2001 28 499 506 10.1016/S8756-3282(01)00413- 6 11344049
29. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. A Yamaguchi T Katagiri T Ikeda, Journal of Cell Biology 1991 113 681 7 1849907 10.1083/jcb.113.3.681 (Pubitemid 21926024)
30. MyoD enhances BMP7-induced osteogenic differentiation of myogenic cell cultures. M Komaki A Asakura MA Rudnicki J Sodek S Cheifetz, Journal of Cell Science 2004 117 1457 68 10.1242/jcs.00965 15020674
31. The muscle transcription factor MyoD promotes osteoblast differentiation by stimulation of the Osterix promoter. J Hewitt X Lu L Gilbert MS Nanes, Endocrinology 2008 149 3698 707 10.1210/en.2007-1556 18372333
32. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts. M Namiki S Akiyama T Katagiri A Suzuki N Ueno N Yamaji V Rosen JM Wozney T Suda, Journal of Biological Chemistry 1997 272 22046 52 10.1074/jbc.272.35.22046 9268344
33. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts. S Akiyama T Katagiri M Namiki N Yamaji N Yamamoto K Miyama H Shibuya N Ueno JM Wozney T Suda, Experimental Cell Research 1997 235 362 9 10.1006/excr.1997.3680 9299160
34. Development of approaches to improve cell survival in myoblast transfer therapy. Z Qu L Balkir JC van Deutekom PD Robbins R Pruchnic J Huard, Journal of Cell Biology 1998 142 1257 67 9732286 10.1083/jcb.142.5.1257
35. The human genome browser at UCSC. WJ Kent CW Sugnet TS Furey KM Roskin TH Pringle AM Zahler D Haussler, Genome Research 2002 12 996 1006 12045153 (Pubitemid 34662293)
36. MatInspector and beyond: promoter analysis based on transcription factor binding sites. K Cartharius K Frech K Grote B Klocke M Haltmeier A Klingenhoff M Frisch M Bayerlein T Werner, Bioinformatics 2005 21 2933 42 10.1093/bioinformatics/bti473 15860560
37. Fibroblasts can be genetically modified to produce excitable cells capable of electrical coupling. E Kizana SL Ginn DG Allen DL Ross IE Alexander, Circulation 2005 111 394 8 10.1161/01.CIR.0000153812.64956.EF 15687125
38. Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2/Cbfa1. BA Byers GK Pavlath JM Murphy G Karsenty AJ Garcia, Journal of Bone & Mineral Research 2002 17 1931 44 10.1359/jbmr.2002.17.11.1931 (Pubitemid 35239193)
39. Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials. EE Pakos JP Ioannidis, International Journal of Radiation Oncology, Biology, Physics 2004 60 888 95 15465207 (Pubitemid 39311770)
40. The origin of osteoprogenitor cells responsible for heterotopic ossification following hip surgery: an animal model in the rabbit. MN Rumi GS Deol KP Singapuri VD Pellegrini Jr, Journal of Orthopaedic Research 2005 23 34 40 10.1016/j.orthres.2004.05.003 15607872
41. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. B Peault M Rudnicki Y Torrente G Cossu JP Tremblay T Partridge E Gussoni LM Kunkel J Huard, Molecular Therapy: the Journal of the American Society of Gene Therapy 2007 15 867 77 17387336 (Pubitemid 46621645)
42. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. A Dellavalle M Sampaolesi R Tonlorenzi E Tagliafico B Sacchetti L Perani A Innocenzi BG Galvez G Messina R Morosetti S Li M Belicchi G Peretti JS Chamberlain WE Wright Y Torrente S Ferrari P Bianco G Cossu, Nature Cell Biology 2007 9 255 67 10.1038/ncb1542 17293855
43. Mesoangioblasts-vascular progenitors for extravascular mesodermal tissues. G Cossu P Bianco, Current Opinion in Genetics & Development 2003 13 537 42 10.1016/j.gde.2003.08.001 14550421
44. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. EM Shore M Xu GJ Feldman DA Fenstermacher TJ Cho IH Choi JM Connor P Delai DL Glaser M LeMerrer R Morhart JG Rogers R Smith JT Triffitt JA Urtizberea MA Zasloff MA Brown FS Kaplan, Nature Genetics 2006 38 525 7 10.1038/ng1783 16642017
45. BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. K Lavery P Swain D Falb MH Alaoui-Ismaili, Journal of Biological Chemistry 2008 283 20948 58 10.1074/jbc.M800850200 18436533